World's Best Scientists 2026 revealed!
Robert B. Jenkins

Robert B. Jenkins

D-Index & Metrics

Medicine

D-Index
131
Citations
78170
World Ranking
2363
National Ranking
1330

Overview

Robert B. Jenkins is affiliated with the Mayo Clinic in the United States. Their research primarily intersects the fields of medicine and biochemistry, genetics, and molecular biology, reflecting a strong focus on areas of genetics and molecular biology within the biomedical sciences.

The scientist has contributed extensively to topics including:

  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Cancer-related Molecular Mechanisms Research
  • MicroRNA in Disease Regulation
  • Cancer, Hypoxia, and Metabolism

Robert B. Jenkins's published body of work spans various high-impact journals, with frequent publication in venues such as:

  • Neuro-Oncology
  • Cancer Genetics
  • Journal of Neuropathology & Experimental Neurology
  • Neuro-Oncology Advances
  • bioRxiv (Cold Spring Harbor Laboratory)

Significant recent papers illustrate the scientist's engagement with glioma research and neuro-oncology. Notable publications include:

  • "Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma," 2020, JAMA Oncology
  • "cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas," 2020, Acta Neuropathologica
  • "Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study," 2021, The Lancet Oncology
  • "Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions," 2022, Neuro-Oncology
  • "Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model," 2021, Radiology

The scientist has collaborated frequently with several fellow researchers, highlighting an active engagement in collaborative research environments. Frequent co-authors include:

  • Jeanette E. Eckel-Passow
  • Daniel H. Lachance
  • Thomas M. Kollmeyer
  • Caterina Giannini
  • Cristiane M. Ida

Robert B. Jenkins's research contributions primarily advance understanding in glioma biology, cancer genetics, and neuro-oncology diagnostics, employing multidisciplinary approaches including radiomics and machine learning methods in medical imaging.

Best Publications

  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

    Edward H. Romond;Edith A. Perez;John Bryant;Vera J. Suman

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Antonio C Wolff;M Elizabeth Hale Hammond;Kimberly H Allison;Brittany E Harvey

  • Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

    Neal I. Lindeman;Philip T. Cagle;Mary Beth Beasley;Dhananjay Arun Chitale

  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

    Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh

  • Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

    L C Hartmann;D J Schaid;J E Woods;T P Crotty

  • Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

    Gregory Cairncross;Meihua Wang;Edward Shaw;Robert Jenkins

  • Genetics of adult glioma

    McKinsey L. Goodenberger;Robert Brian Jenkins

  • A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

    Robert B. Jenkins;Hilary Blair;Karla V. Ballman;Caterina Giannini

  • Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas

    Justin S. Smith;Arie Perry;Thomas J. Borell;Hyun K. Lee

  • Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

    Gregory Cairncross;B. Berkey;Edward G. Shaw;Robert Brian Jenkins

  • Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers

    Lynn C. Hartmann;Thomas A. Sellers;Daniel J. Schaid;Thomas S. Frank

  • BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice.

    Darren J. Baker;Karthik B. Jeganathan;J. Douglas Cameron;Michael Thompson

  • Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Jan C. Buckner;Matthew J. Maurer;Jeffrey I. Kreisberg

  • Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

    P. Cairns;T. J. Polascik;Y. Eby;K. Tokino

  • cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

    Daniel J. Brat;Kenneth Aldape;Howard Colman;Eric C. Holland

  • PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

    Justin S. Smith;Issei Tachibana;Sandra M. Passe;Brenda K. Huntley

  • The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

    John R. Prensner;Matthew K. Iyer;Anirban Sahu;Irfan A. Asangani

  • Sporadic Medulloblastomas Contain PTCH Mutations

    Corey Raffel;Robert B. Jenkins;Lori Frederick;Deanne Hebrink

  • The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

    Kui Ming Chan;Dong Fang;Haiyun Gan;Rintaro Hashizume

  • Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

    Robert B. Jenkins;Junqi Qian;Michael M. Lieber;David G. Bostwick

Frequent Co-Authors

Margaret R. Wrensch
Margaret R. Wrensch University of California, San Francisco
Melissa L. Bondy
Melissa L. Bondy Stanford University
Jill S. Barnholtz-Sloan
Jill S. Barnholtz-Sloan Case Western Reserve University
John K. Wiencke
John K. Wiencke University of California, San Francisco
Jan C. Buckner
Jan C. Buckner Mayo Clinic
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research
Karla V. Ballman
Karla V. Ballman Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in expanding your healthcare career options or want a flexible route into the medical field, there are many alternative pathways available online. For aspiring nurses, some nursing school no entrance exam programs provide opportunities to begin your nursing journey without the stress of standardized testing.

For those drawn to leadership roles, enrolling in an online healthcare management degree can open doors to managing hospital operations, clinics, or public health organizations. Nurses with an associate degree can advance their qualifications and move into primary care by exploring accredited adn to fnp programs.

If you're passionate about nutrition and wellness, consider an online nutritionist degree to prepare for roles in community health, clinical practice, or health education. These online programs offer flexibility, help you balance your studies with other responsibilities, and give you a solid foundation for advancing your healthcare career.

Best Scientists Citing Robert B. Jenkins

Trending Scientists